CMMB — Chemomab Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapMomentum Trap

Annual balance sheet for Chemomab Therapeutics, fiscal year end - December 31st, millions except per share.

	2019 December 31st	R2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:		10-Q	10-K	10-K	20-F
Standards:	—	USG	USG	USG	USG
Status:	fx Preliminary	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	—	11.7	61.2	39.9	19.8
Prepaid Expenses
Total Other Current Assets
Total Current Assets	—	11.8	62.7	41.7	20.9
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	—	0.58	0.702	0.594	0.695
Other Long Term Assets
Total Assets	—	12.5	64.4	43.1	22.2
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	—	1.32	2.65	6.75	4.84
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	—	1.67	2.89	6.84	5.15
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	—	10.8	61.5	36.2	17
Total Liabilities & Shareholders' Equity	—	12.5	64.4	43.1	22.2
Total Common Shares Outstanding